PROVIDER PROFILE · NPI 1023252350
Erik CabralM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,297
Unique beneficiaries
—
Total services
18,342
Distinct HCPCS
29
Medicare payment
$423K
Peer benchmark
Total Medicare services vs. 1,546 Dermatology providers in CA — top quintile (cohort median 2,504).
PRESCRIBING · PART D · 2024
Total Rx claims
583
Beneficiaries
—
Total drug cost
$16K
Distinct drugs
13
Brand share
16.0%
Top prescribed drugs
Mupirocin131 claims
Fluocinonide79 claims
Sulfamethoxazole/Trimethoprim72 claims
Triamcinolone Acetonide47 claims
Ketoconazole46 claims
QUALITY · MIPS · 2024
Final MIPS score
97.7
Quality
85.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.95%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$240
Payment records
16
By payment type
Food and Beverage$216
Education$24
Top paying entities
Food and Beverage$216
Education$24
REFERRAL NETWORK
Where Erik Cabral's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 1 outbound destinations.
Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Unilab Corporation Clinical Laboratory · San Jose, CA | 13 | 37 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE